| What's the path to recouping that money? Even if every major company in the US spends $100,000 a year on subscriptions and every household spends $20/month, it still doesn't seem like enough return on investment when you factor in inference costs and all the other overhead. New medical discoveries, maybe? I saw OpenAI's announcement about gpt-bio and iPSCs which was pretty amazing, but there's a very long gap between that and commercialization. I'm just wondering what the plan is. |